Coming to Your iPad in 2013: DSM-5 and Changes in Biopharma Research Methods
Editor’s note: Mike Williams is an adjunct professor in the Feinberg School of Medicine, Northwestern University in Chicago, from where he shares his personal views on today’s drug discovery industry.

Read more on BioWorld